Tg(tetO-LRRK2*G2019S)1Cai
Transgene Detail
|
Symbol: |
Tg(tetO-LRRK2*G2019S)1Cai |
Name: |
transgene insertion 1, Huaibin Cai |
MGI ID: |
MGI:4414665 |
Transgene: |
Tg(tetO-LRRK2*G2019S)1Cai Location: unknown
|
Alliance: |
Tg(tetO-LRRK2*G2019S)1Cai page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(tetO-LRRK2*G2019S)1Cai expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
LRRK2 (120892) |
|
|
|
|
|
Mutation details: The tet operator drives expression of the human cDNA with nucleotide substitutions that result in the amino acid substitution of serine for glycine at position 2019 (G2019S). This mutation is commonly observed in patients with Parkinson's disease and is thought to increase the kinase activity of the protein. No line information given.
(J:154755)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:154755 Parisiadou L, et al., Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci. 2009 Nov 4;29(44):13971-80 |
All: |
1 reference(s) |
|